Log in
Enquire now

List of SBIR/STTR awards granted to Haematologic Technologies, Inc.

List of SBIR/STTR awards granted to Haematologic Technologies, Inc.
List of SBIR/STTR awards granted to Alan Penn & Associates Inc
List of SBIR/STTR awards granted to Electro Standards Laboratory, Inc.
List of SBIR/STTR awards granted to Universal Technology Corporation
List of Plug and Play Enterprise Tech Batch 3 companies
List of Qnovo patents
where
SBIR/STTR Award Recipient
is
‌
Haematologic Technologies, Inc.
Name
Description
SBIR/STTR Award Recipient
Government Agency
Government Branch
Award Type
Contract Number (US Government)
Award Phase
Award Amount (USD)
Date Awarded
Official Website
‌
Haematologic Technologies, Inc. SBIR Phase I Award, July 2018

A SBIR Phase I contract was awarded to Haematologic Technologies, Inc. in July, 2018 for $180,171.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.

‌
Haematologic Technologies, Inc.
National Institutes of Health
National Institutes of Health
SBIR
1R43HL144261-01
Phase I
180,171
July 15, 2018
sbir.gov/node/1570831
‌
Haematologic Technologies, Inc. STTR Phase I Award,

A STTR Phase I contract was awarded to Haematologic Technologies, Inc. for $99,039.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
STTR
1R41HL076904-01
Phase I
99,039
sbir.gov/content/global-test-hemostatic-risk-0
‌
Haematologic Technologies, Inc. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Haematologic Technologies, Inc. for $328,891.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
SBIR
2R44HL073532-02
Phase II
328,891
sbir.gov/content/fluorogenic-assays-factor-vlla-and-tissue-factor-2
‌
Haematologic Technologies, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Haematologic Technologies, Inc. for $74,217.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
SBIR
1R43HL073532-01
Phase I
74,217
sbir.gov/content/fluorogenic-assays-factor-vlla-and-tissue-factor-0
‌
Haematologic Technologies, Inc. SBIR Phase II Award,

A SBIR Phase II contract was awarded to Haematologic Technologies, Inc. for $681,228.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
SBIR
2R44HL073541-02
Phase II
681,228
sbir.gov/content/murine-reagents-and-analytical-tools-2
‌
Haematologic Technologies, Inc. STTR Phase II Award,

A STTR Phase II contract was awarded to Haematologic Technologies, Inc. for $351,562.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
STTR
2R42HL076904-02
Phase II
351,562
sbir.gov/content/global-test-hemostatic-risk-2
‌
Haematologic Technologies, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Haematologic Technologies, Inc. for $99,039.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
SBIR
1R41HL076904-01
Phase I
99,039
sbir.gov/node/1066593
‌
Haematologic Technologies, Inc. SBIR Phase I Award,

A SBIR Phase I contract was awarded to Haematologic Technologies, Inc. for $75,000.0 USD from the U.S. Department of Health & Human Services.

‌
Haematologic Technologies, Inc.
SBIR
1R43HL073541-01
Phase I
75,000
sbir.gov/content/murine-reagents-and-analytical-tools-0
8 results
0 selected
8 results
0 selected
Golden logo

Company

  • Home
  • Pricing
  • Become an Editor
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us

Explore companies

  • Artificial Intelligence
  • Fintech
  • Biotechnology
  • Cybersecurity
  • Semiconductors
  • Electric Vehicles
  • Cloud Computing
  • Robotics
  • SaaS
  • Renewable Energy
  • Venture Capital
  • Blockchain
  • Browse all →